The latest update is out from Firebrick Pharma Limited ( (AU:FRE) ).
Firebrick Pharma Limited has announced a change in the substantial holding of shares by Peter Laurence Molloy and related parties. The change, effective March 5, 2025, resulted in a decrease in voting power from 15.80% to 14.35% due to a dilutionary effect from a private placement. This adjustment in shareholding could impact the company’s control dynamics and influence within the market.
More about Firebrick Pharma Limited
Firebrick Pharma Limited operates in the pharmaceutical industry, focusing on the development and commercialization of healthcare products.
YTD Price Performance: 53.33%
Average Trading Volume: 178,145
Technical Sentiment Consensus Rating: Sell
For an in-depth examination of FRE stock, go to TipRanks’ Stock Analysis page.